Acute kidney injury after liver cancer ablation: Risk factors and perioperative management

Table 3 Laboratory indicators

Indicators	AKI group (n = 25)	Non-AKI group (n = 143)	t	P value
Hemoglobin (g/L)	114.20 ± 16.53	135.46 ± 13.79	6.897	< 0.001
Total bilirubin (μmol/L)	20.57 ± 4.57	19.85 ± 5.33	0.635	0.526
Serum albumin (g/L)	37.20 ± 3.92	36.11 ± 4.50	1.137	0.257
Urea nitrogen (mmol/L)	6.23 ± 1.84	5.84 ± 1.59	1.105	0.271
Uric acid (μmol/L)	383.36 ± 110.99	341.54 ± 82.64	2.210	0.029
Creatinine (μmol/L)	93.08 ± 24.15	77.73 ± 16.59	3.960	< 0.001
Serum sodium (mmol/L)	137.88 ± 4.03	138.47 ± 3.29	0.799	0.426
HDL-C (mmol/L)	1.03 ± 0.25	1.09 ± 0.31	0.916	0.361
LDL-C (mmol/L)	2.77 ± 0.53	2.66 ± 0.72	0.729	0.467

AKI: Acute kidney injury; HDL-C/LDL-C: High-/Low-density lipoprotein cholesterol.